Cellebrite DI Ltd.
CLBT
$11.43
-$0.02-0.18%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 15.77% | 18.13% | 18.35% | 20.06% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 15.77% | 18.13% | 18.35% | 20.06% | |
| Cost of Revenue | 42.60% | 11.72% | 8.71% | 31.86% | |
| Gross Profit | 10.81% | 19.37% | 20.32% | 18.00% | |
| SG&A Expenses | 19.88% | 16.69% | 21.49% | 15.13% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 25.62% | 15.74% | 18.78% | 18.60% | |
| Operating Income | -51.80% | 32.31% | 15.46% | 32.67% | |
| Income Before Tax | -46.19% | 32.03% | 194.44% | 127.88% | |
| Income Tax Expenses | 266.24% | 697.77% | -26.78% | -5.63% | |
| Earnings from Continuing Operations | -67.29% | 10.34% | 181.79% | 124.38% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -67.29% | 10.34% | 181.79% | 124.38% | |
| EBIT | -51.80% | 32.31% | 15.46% | 32.67% | |
| EBITDA | -6.73% | 34.10% | 12.92% | 24.92% | |
| EPS Basic | -68.27% | 2.42% | 167.67% | 120.22% | |
| Normalized Basic EPS | -47.87% | 25.52% | 178.18% | -- | |
| EPS Diluted | -67.96% | 1.78% | 166.17% | 119.31% | |
| Normalized Diluted EPS | -46.93% | 29.82% | 175.43% | -- | |
| Average Basic Shares Outstanding | 3.02% | 5.16% | 20.81% | 20.54% | |
| Average Diluted Shares Outstanding | 1.53% | 1.68% | 25.15% | 26.66% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |